UnratedDrug recall · FDA · Published December 31, 2021
Rubicon Research Metoprolol Tablets Recall: Foreign Metal in Tablets
Rubicon Research recalls 25mg Metoprolol Tartrate tablets due to metal foreign matter. Rx-only bottles distributed by TruPharma. No remedy stated in official notice.
“Rubicon Research Metoprolol Tablets Recall: Foreign Metal in Tablets.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35410-rubicon-research-metoprolol-tablets-recall-foreign-metal-in-tablets. Based on FDA recall #D-0362-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0362-2022%22&limit=1).
The FDA announced on Dec. 31, 2021, that Rubicon Research Private Limited voluntarily recalled Metoprolol Tartrate Tablets USP 25 mg due to complaints of foreign metal matter embedded in the tablets. The agency classified the recall as Class II.
The recall was initiated after complaints were received of foreign matter, specifically metal, embedded in the tablets. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Rubicon Research Private Limited has issued three other recalls since April 26, 2024, including a May 6, 2024, recall for metal in Metoprolol Tablets and an Aug. 24, 2024, recall for discoloration in AcetaZOLAMIDE Tablets. Other recent recalls of similar products include Guardian Drug Goodsense Ultra Strength Antacid Tablets Recall (May 28, 2026), Guardian Drug Family Wellness Antacid Tablets Recall (May 28, 2026), and Guardian Market Basket Antacid Recall (May 28, 2026).
How to tell if you have this one
Check for the 25mg Metoprolol Tartrate tablets in 1000-count bottles with NDC 52817-360-00. The bottles were distributed by TruPharma in Tampa, Florida.
Brand
Rubicon Research
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check for Recalled Product
Look for the 25mg Metoprolol Tartrate tablets in 1000-count bottles with NDC 52817-360-00 distributed by TruPharma.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Product was distributed to one distributor who may have distributed the product further nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 10 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0362-2022 (December 31, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0362-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.